Filing search / Context Therapeutics Inc. / "Responsible"

Search information

Context Therapeutics Inc.

Companies

"Responsible"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

100 results

Newest first Best match first

S-3

EX-4.3

CNTX Context Therapeutics Inc.

Shelf registration

Amounts in respect of, the Security. “Responsible Officer” means any officer of the Trustee in its Corporate Trust Office having responsibility … , if any, responsible for overseeing such composite currency; 2.2.14. the designation of the currency, currencies or currency units in which payment

6 Nov 24

4:42pm

S-3

CNTX Context Therapeutics Inc.

Shelf registration

, responsible for overseeing such composite currency; the designation of the currency, currencies or currency units in which payment of principal of, premium … and if it is known to a responsible officer of the trustee, the trustee shall mail to each holder of the securities of that series notice

6 Nov 24

4:42pm

10-Q

2024 Q3

EX-31.1

CNTX Context Therapeutics Inc.

Quarterly report

of the registrant as of, and for, the periods presented in this report; 4.The registrant’s other certifying officer and I are responsible

6 Nov 24

4:02pm

10-Q

2024 Q3

CNTX Context Therapeutics Inc.

Quarterly report

the exclusive right to ONA-XR and was solely responsible for the development and commercialization of ONA-XR in China, Hong Kong and Macau. The Company

6 Nov 24

4:02pm

10-Q

2024 Q3

EX-31.2

CNTX Context Therapeutics Inc.

Quarterly report

flows of the registrant as of, and for, the periods presented in this report; 4.The registrant’s other certifying officer and I are responsible

6 Nov 24

4:02pm

Context to obtain exclusive development and commercialization rights to BA3362

Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors

Context Therapeutics Appoints Dr. Karen Smith and Dr. Luke Walker to Board of Directors

7 Aug 24

4:07pm

7 Aug 24

4:07pm

7 Aug 24

4:07pm

10-Q

1cjli6km3rt

Quarterly report

7 Aug 24

4:07pm

Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

8 May 24

4:03pm

10-Q

aai8x601mn5i r0

Quarterly report

8 May 24

4:03pm

8 May 24

4:03pm

Context Therapeutics Announces $100 Million Private Placement

Context Therapeutics Announces $100 Million Private Placement

Context Therapeutics Announces $100 Million Private Placement

26 Apr 24

4:10pm

Filing search / Context Therapeutics Inc. / "Responsible"

100 results

Top filers

Top filing types

Recent filing years